Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02560285
Other study ID # USaoPauloGH1001
Secondary ID 1.289.986
Status Recruiting
Phase N/A
First received June 30, 2015
Last updated October 31, 2017
Start date January 2016
Est. completion date February 2020

Study information

Verified date October 2017
Source University of Sao Paulo General Hospital
Contact Omar AV Mejía, MD, PhD
Phone 55-11-26615000
Email omarvmejia@sbccv.org.br
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Over time there is a need to improve old and develop new risk models. Overall the assessment of mortality risk in cardiac surgery is performed with the use of preoperative risk models. The use of improved risk models and increased accuracy in the technique of preparing these mathematical systems does not have a positive impact on the level of prediction, which is still inaccurate, especially in the considered group of high risk. New models need to be built not only for a better prediction of mortality risk, if not also to predict morbidity in the group of patients at higher risk of complications after cardiac surgery procedures.

The aim of this study is:

- To construct the HiriSCORE to identify patients at higher risk of complications after cardiac surgery procedures

- Assessing the impact of pre-, intra- and postoperative period to the prognosis of morbidity and mortality in high-risk patients undergoing cardiac surgery procedures.


Description:

The risk predicts models are the mathematical tools for identification of the patients with complications risk after cardiac surgery procedures.

Over time, however, due to technical progress (the development of hybrid surgery, new valves and prostheses), the development of new drugs, changes in the environment and social conditions in which do patients live, there is a need to improve old and develop new models. Based on the statement that high risk patients have similar characteristics (clinical and laboratory) regardless of the procedure to which they were submitted, creating a new risk score to this group of patients must be sought. Improving the model quality was achieved by using more accurate risk assessments. In general, the assessment of mortality risk in cardiac surgery is performed with the use of preoperative risk models (EuroSCORE II, STS-score). However, the use of improved risk models and increased accuracy in the technique of preparing these mathematical systems, unfortunately, does not have a positive impact on the level of prediction, which is still inaccurate, especially in the considered group of high risk. New models need to be built not only for a better prediction of mortality risk, if not also to predict morbidity in the group of patients at higher risk of complications after cardiac surgery procedures.

The aim of this study is:

- To construct the HiriSCORE to identify patients at higher risk of complications after cardiac surgery procedures (the investigators have proposed a high-risk evaluation criteria: EuroSCORE II> 5 or STS-score> 5);

- Assessing the impact of pre-, intra- and postoperative period to the prognosis of subsequent morbidity and mortality in high-risk patients who have passed cardiac surgery procedures.

It was decided to conduct this research in two phases. The developmental phase is carried out for 30 months and includes an analysis of at least 2,000 patients who will pass cardiac surgery procedures in institutions and hospitals involved in the study. After this analysis, including outcomes, will be constructed the HiriSCORE, a new test-model for high-risk patients. In the validation phase of the study, which will involve a further 1,000 patients it is planned preparation and verification of effectiveness of the HiriSCORE model where it will be compared to the STS Score and the EuroSCORE II.

The study will include the patients of 18 years old or older who have undergone cardiac surgery procedures, such as coronary artery bypass grafting (isolated or combined with any heart valve intervention), heart valve surgery, and surgery on the ascending aorta (only combined with operations on the aortic valve or CABG).

Totally, it is proposed assessment of 170 variables (factors perceived risk) for each patient (preoperative, intraoperative, and up to 12 hours after surgery).

The study of mortality and postoperative complications such as renal replacement therapy, stroke, reoperation for bleeding, respiratory failure, cardiogenic shock, will be carried out within 30 days after cardiac surgery procedures.


Recruitment information / eligibility

Status Recruiting
Enrollment 3000
Est. completion date February 2020
Est. primary completion date September 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients undergoing cardiac surgery procedures, such as coronary artery bypass grafting, heart valve surgeries, co-operations on aorta and valve or CABG and variations of this procedures, regardless of the operation or treatment outcomes

- Mortality risk with STS score>5 or EuroSCORE II>5

Exclusion Criteria:

- Isolated surgery on ascending aorta, aortic arch or descending aorta

- Heart transplantation

- Impossibility to include patient´s data in research

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Brazil Fabio B Jatene, MD, PhD São Paulo

Sponsors (13)

Lead Sponsor Collaborator
University of Sao Paulo General Hospital Beneficência Portuguesa de São Paulo, Cardiology Institute of the Distrito Federal, Brazil, Clinical Hospital Samuel Libânio of Pouso Alegre, Brazil, Dante Pazzanese Institute of Cardiology, Brazil, Fuwai Hospital, China, Hospital de Base, InCor Heart Institute, National Institute of Cardiology, Laranjeiras, Brazil, Novosibirsk Cardiology Recearch and Production Center, Russia, Russian Cardiology Research and Production Center, Russia, Santa Casa de Misericórdia of Marília, Brazil, TotalCor Hospital, Brazil

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mortality analysis Patient´s mortality data collection following 30 days after the main procedure 30 days
Secondary Stroke with neurological consequences (pareses or plegia) Stroke with neurological consequences (pareses or plegia) following 30 days after the main procedure 30 days
Secondary ST-elevation Myocardial infarction ST- elevation Myocardial infarction following 30 days after the main procedure 30 days
Secondary Non- ST- elevation Myocardial infarction Non- ST- elevation Myocardial infarction following 30 days after the main procedure 30 days
Secondary Deep sternal wound infection Deep sternal wound infection following 30 days after the main procedure 30 days
Secondary Bleeding requiring reoperation Bleeding requiring reoperation following 30 days after the main procedure 30 days
Secondary Sepsis Sepsis following 30 days after the main procedure 30 days
Secondary Endocarditis Endocarditis following 30 days after the main procedure 30 days
Secondary Respiratory failure Respiratory failure following 30 days after the main procedure 30 days
Secondary Renal replacement therapy Renal replacement therapy following 30 days after the main procedure 30 days
Secondary Hepatic failure Hepatic failure following 30 days after the main procedure 30 days
Secondary Unplanned cardiac reoperation Unplanned cardiac reoperation following 30 days after the main procedure 30 days
Secondary Unplanned cardiac percutaneous intervention Unplanned cardiac percutaneous intervention following 30 days after the main procedure 30 days
See also
  Status Clinical Trial Phase
Recruiting NCT02908009 - A Case Control Study to Identify the Role of Epigenetic Regulation of Genes Responsible for Energy Metabolism and Mitochondrial Function in the Obesity Paradox in Cardiac Surgery
Completed NCT01998438 - Prospective Trial of Tranexamic Acid in Cardiac Surgery Phase 4
Completed NCT01805466 - Effects on Organ Damage and Surgical Outcome of a New Cardiopulmonary Pass System (EVADO) N/A
Completed NCT02658006 - Evaluation of Monitoring TECHNOlogies in the PERI-OPerative Care of Cardiac Surgical Patients N/A
Completed NCT02571920 - Hemodynamic Monitoring, Positive Inotropic and Vasoactive Drugs During Cardiac Surgery (EMOA) N/A
Completed NCT02267538 - Dexmedetomidine and Delirium in Patients After Cardiac Surgery Phase 4
Completed NCT02866825 - Studying Complement Inhibition in Complex Cardiac Surgery Phase 2
Completed NCT02513862 - Prospective Trial of Autologous Platelet Rich Plasma in Aortic Surgery N/A
Completed NCT02560519 - Albumin in Cardiac Surgery Phase 4
Recruiting NCT03884725 - Fibrinogen Concentrate In Children Cardiac Surgery 2 Phase 4
Recruiting NCT01879475 - Safety and Performance of 032-11 Haemostat in Cardiac and Thoracic Aortic Surgery N/A
Completed NCT00598195 - Ketamine Pharmacokinetics in Children Having Heart Surgery N/A
Completed NCT02972684 - Cost-Utility Analysis of Management of Peri Operative Haemorrhage Following Cardiac Surgery With Cardiopulmonary Bypass N/A
Terminated NCT02793895 - Detection of Atrial Fibrillation After Cardiac Surgery N/A
Active, not recruiting NCT03343418 - Effects of Prophylactic Desmopressin on Blood Coagulation Parameters in Heart Valve Surgery Phase 4
Recruiting NCT03469440 - Goal Directed Therapy Aiming to Optimise Oxygen Central Venous Saturation in Children Undergoing Cardiac Surgery N/A
Recruiting NCT03882593 - Blood Cell Adhesion to Arterial Filters During Cardiac Surgery
Withdrawn NCT02119806 - Decreasing the Incidence of Delirium After Cardiac Surgery Phase 4
Completed NCT02831907 - Portal Flow Pulsatility as a Risk Factor for Acute Kidney Injury After Cardiac Surgery N/A
Recruiting NCT02745951 - HELIox CardiOPlegia Trial During Cardiac surgERy N/A